ADALIMUMAB INDUCTION AND MAINTAINING REMISSION FOR CROHN'S DISEASE IN PATIENT WHO LOST RESPONSE TO INFLIXIMAB. Case report

• Egile Nagusiak: Ivaylo Vazharov (Egilea), Hristo Bozov (Egilea), Snezha Zlateva (Egilea), Georgi Bonchev (Egilea)
• Formatua: Liburua
• Argitaratua: Peytchinski Publishing, 2016-12-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

This is a report of 30 years old woman suffering from Crohn's disease who had a good clinical response to Infliximab (Remicade) at first, but during the treatment after 5 months she lost response. After receiving Adalimumab (Humira) clinical remission was reached on the day 20. The case demonst...